Understanding Mechanisms & Compressing Morbidity in Aging Humans
A plethora of genetic, dietary and pharmacological interventions can extend healthy lifespan in laboratory animals, and can delay or ameliorate diverse aging-related diseases. Many of the signalling pathways involved are evolutionarily conserved, and are starting to be implicated in human aging. This raises the intriguing possibility of performing preventative medicine against the chronic diseases of our time by targeting the main risk factor for all of them, namely aging. Two important current challenges in the field are (1) to understand the downstream pathways by which longevity interventions combat age-related loss of function and pathology, and (2) to translate the findings into the extension of human healthspan.
As more individuals wish to stay in their homes, as opposed to institutionalized settings such as nursing homes, the demand for quality trained... Read More
By integrating our efforts we are able to provide better outcomes, enhance recovery, improve quality of life, address needs, and maximize the... Read More